Carima showcased the ZENESIS bio-3D printer featuring a direct-to-glass printing technique that main...

Carima showcased the ZENESIS bio-3D printer featuring a direct-to-glass printing technique that maintains over 90% cell viability. The system produces 300 samples per minute, representing a 144x productivity leap over manual methods and reducing labor costs by 20%. By integrating freeze-dried EZ-preBioink capsules, the platform eliminates traditional bio-ink instability and preparation bottlenecks. This advancement signals a shift toward industrial-grade automated bio-fabrication for high-throughput drug screening and organ-on-a-chip research. 🧬🔬 #3DPrinting #Biotech #AdditiveManufacturing #Innovation #BioPrinting